Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07663448 · ClinicalTrials.gov registry record · NA

Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention

A NA study, sponsored by Brown University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target

NCT07663448: Recruiting NA study, sponsored by Brown University.

NCT07663448 is a NA study that is actively recruiting participants, run by Brown University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07663448, a NA study, is actively recruiting participants, sponsored by Brown University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The goal of this treatment development project is to develop and pilot an adaptive mobile health (mHealth) intervention that targets the co-use of alcohol and opioids in young adults.

Primary Outcome

The number of participants who complete all weeks of the mHealth intervention.

Interventions

  • BEHAVIORAL mHealth Intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-06-08
Est. Completion 2027-04-30
Phase NA
Brown University

231 total trials

What NCT07663448 shows while recruiting

NCT07663448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which mHealth Intervention is the first listed.

NCT07663448 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07663448 about?

NCT07663448 is a clinical study titled "Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention". The goal of this treatment development project is to develop and pilot an adaptive mobile health (mHealth) intervention that targets the co-use of alcohol and opioids in young adults.

What is the current status of trial NCT07663448?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-06-08. Estimated completion is 2027-04-30.

What interventions are being tested in trial NCT07663448?

The interventions under investigation include: mHealth Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07663448?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07663448's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07663448, the US trial registry maintained by the National Library of Medicine. NCT07663448 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.